Literature DB >> 26340079

Transdiagnostic mechanisms in depression and anxiety: The role of rumination and attentional control.

Kean J Hsu1, Courtney Beard2, Lara Rifkin3, Daniel G Dillon4, Diego A Pizzagalli4, Thröstur Björgvinsson2.   

Abstract

BACKGROUND: Deficits in attentional control have been hypothesized to cause rumination, suggesting that the relationships between attentional control and clinical symptoms may be mediated in part by rumination. However, to date, no clinical study has examined these constructs transdiagnostically in a path analysis model.
METHODS: Fifty-one adults presenting for treatment completed measures of self-reported attentional control, rumination, and depression and anxiety symptoms. A bias-corrected path analysis-based approach was employed to test whether indirect (i.e., mediating) effects of rumination were significantly associated with the direct effects of attentional control on depression and anxiety symptoms. Separate models for depression and anxiety symptoms were tested along with reverse models using attentional control as a proposed mediator.
RESULTS: The relationship between attentional control and clinical symptomatology (i.e., both depression and anxiety symptoms) was mediated by rumination. Poor attentional control was associated with more rumination and consequently more severe symptoms of depression and anxiety. The reverse relationship (i.e., attentional control mediating the relationship between rumination and depression or anxiety symptoms) was not significant. LIMITATIONS: Study design did not allow testing of temporal precedence for the mediation models. All constructs were assessed via self-report.
CONCLUSIONS: Attentional control appears to impact depression and anxiety symptoms through rumination. The pathway between poor attentional control and emotion dysregulation via rumination suggests that interventions targeting attentional control may decrease maladaptive ruminative processes, leading to improved emotion regulation and reduced clinical symptomatology. Future studies should examine the stability of this mediational relationship over time (and in the face of targeted interventions).
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Attentional control; Depression; Mediation; Rumination

Mesh:

Year:  2015        PMID: 26340079      PMCID: PMC4765997          DOI: 10.1016/j.jad.2015.08.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  41 in total

1.  The response styles theory of depression: tests and an extension of the theory.

Authors:  N Just; L B Alloy
Journal:  J Abnorm Psychol       Date:  1997-05

Review 2.  The modification of attentional bias to emotional information: A review of the techniques, mechanisms, and relevance to emotional disorders.

Authors:  Michael Browning; Emily A Holmes; Catherine J Harmer
Journal:  Cogn Affect Behav Neurosci       Date:  2010-03       Impact factor: 3.282

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Brooding and reflective rumination among suicide attempters: cognitive vulnerability to suicidal ideation.

Authors:  Katherine Surrence; Regina Miranda; Brett M Marroquín; Shirley Chan
Journal:  Behav Res Ther       Date:  2009-06-12

5.  Anxiety-related attentional biases and their regulation by attentional control.

Authors:  Douglas Derryberry; Marjorie A Reed
Journal:  J Abnorm Psychol       Date:  2002-05

6.  Effectiveness of cognitive behavior therapy for severe mood disorders in an acute psychiatric naturalistic setting: a benchmarking study.

Authors:  Thröstur Björgvinsson; Sarah J Kertz; Joseph S Bigda-Peyton; David H Rosmarin; Idan M Aderka; Edmund C Neuhaus
Journal:  Cogn Behav Ther       Date:  2014-03-31

7.  Cognitive impairment in the euthymic phase of chronic unipolar depression.

Authors:  S Paradiso; G J Lamberty; M J Garvey; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1997-12       Impact factor: 2.254

8.  Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population.

Authors:  Bernd Löwe; Oliver Decker; Stefanie Müller; Elmar Brähler; Dieter Schellberg; Wolfgang Herzog; Philipp Yorck Herzberg
Journal:  Med Care       Date:  2008-03       Impact factor: 2.983

9.  A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta Earthquake.

Authors:  S Nolen-Hoeksema; J Morrow
Journal:  J Pers Soc Psychol       Date:  1991-07

10.  Rumination and worrying as possible mediators in the relation between neuroticism and symptoms of depression and anxiety in clinically depressed individuals.

Authors:  Jeffrey Roelofs; Marcus Huibers; Frenk Peeters; Arnoud Arntz; Jim van Os
Journal:  Behav Res Ther       Date:  2008-10-14
View more
  20 in total

1.  Transdiagnostic psychiatry: a systematic review.

Authors:  Paolo Fusar-Poli; Marco Solmi; Natascia Brondino; Cathy Davies; Chungil Chae; Pierluigi Politi; Stefan Borgwardt; Stephen M Lawrie; Josef Parnas; Philip McGuire
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

2.  Disentangling the effects of attentional difficulties on fears of social evaluation and social anxiety symptoms: Unique interactions with sluggish cognitive tempo.

Authors:  Joseph W Fredrick; Stephen P Becker; Michael J Kofler; Matthew A Jarrett; G Leonard Burns; Aaron M Luebbe
Journal:  J Psychiatr Res       Date:  2020-08-27       Impact factor: 4.791

3.  Sluggish cognitive tempo and ADHD symptoms in relation to task-unrelated thought: Examining unique links with mind-wandering and rumination.

Authors:  Joseph W Fredrick; Michael J Kofler; Matthew A Jarrett; G Leonard Burns; Aaron M Luebbe; Annie A Garner; Sherelle L Harmon; Stephen P Becker
Journal:  J Psychiatr Res       Date:  2020-01-29       Impact factor: 4.791

4.  Cognitive Attentional Syndrome and Metacognitive Beliefs in Male Sexual Dysfunction: An Exploratory Study.

Authors:  Simona Giuri; Gabriele Caselli; Chiara Manfredi; Daniela Rebecchi; Antonio Granata; Giovanni Maria Ruggiero; Guido Veronese
Journal:  Am J Mens Health       Date:  2016-06-08

5.  Anterior cingulate cortex activity during attentional control corresponds with rumination in depression and social anxiety.

Authors:  Michelle K Sheena; Jagan Jimmy; Katie L Burkhouse; Heide Klumpp
Journal:  Psychiatry Res Neuroimaging       Date:  2021-09-06       Impact factor: 2.376

6.  Set Shifting and Inhibition Deficits as Potential Endophenotypes for Depression.

Authors:  Huiting Liu; Carter J Funkhouser; Scott A Langenecker; Stewart A Shankman
Journal:  Psychiatry Res       Date:  2021-04-10       Impact factor: 11.225

7.  The Psychometric Properties of Attentional Control Scale and Its Relationship with Symptoms of Anxiety and Depression: A Study on Iranian Population.

Authors:  Imaneh Abasi; Parvaneh Mohammadkhani; Abbas Pourshahbaz; Behrouz Dolatshahi
Journal:  Iran J Psychiatry       Date:  2017-04

8.  Understanding Dysregulated Behaviors and Compulsions: An Extension of the Emotional Cascade Model and the Mediating Role of Intrusive Thoughts.

Authors:  Stefanie M Jungmann; Noelle Vollmer; Edward A Selby; Michael Witthöft
Journal:  Front Psychol       Date:  2016-06-29

9.  Unlocking Neurocognitive Substrates of Late-Life Affective Symptoms Using the Research Domain Criteria: Worry Is an Essential Dimension.

Authors:  Sherry A Beaudreau; Nathan C Hantke; Nehjla Mashal; Christine E Gould; Victor W Henderson; Ruth O'Hara
Journal:  Front Aging Neurosci       Date:  2017-11-21       Impact factor: 5.750

10.  Attentional Control and Fear Extinction in Subclinical Fear: An Exploratory Study.

Authors:  Eduard Forcadell; David Torrents-Rodas; Devi Treen; Miquel A Fullana; Miquel Tortella-Feliu
Journal:  Front Psychol       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.